Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 190 entries
Sorted by: Best Match Show Resources per page
Antidiarrheal Effect of DLBS1Y62, a Bioactive Fraction of .

Journal of experimental pharmacology

Wibowo DA, Nailufar F, Tjandrawinata RR.
PMID: 34290534
J Exp Pharmacol. 2021 Jul 15;13:669-675. doi: 10.2147/JEP.S299001. eCollection 2021.

BACKGROUND: Diarrhea is a common health problem worldwide, especially in developing countries. It is the second leading cause of mortality for children. METHODS: DLBS1Y62 was obtained by crushing and milling the dried sap extract of RESULTS: DLBS1Y62 at all...

Cite
Wibowo DA, Nailufar F, Tjandrawinata RR. Antidiarrheal Effect of DLBS1Y62, a Bioactive Fraction of . J Exp Pharmacol. 2021;13:669-675doi: 10.2147/JEP.S299001.
Wibowo, D. A., Nailufar, F., & Tjandrawinata, R. R. (2021). Antidiarrheal Effect of DLBS1Y62, a Bioactive Fraction of . Journal of experimental pharmacology, 13669-675. https://doi.org/10.2147/JEP.S299001
Wibowo, Dicky A, et al. "Antidiarrheal Effect of DLBS1Y62, a Bioactive Fraction of ." Journal of experimental pharmacology vol. 13 (2021): 669-675. doi: https://doi.org/10.2147/JEP.S299001
Wibowo DA, Nailufar F, Tjandrawinata RR. Antidiarrheal Effect of DLBS1Y62, a Bioactive Fraction of . J Exp Pharmacol. 2021 Jul 15;13:669-675. doi: 10.2147/JEP.S299001. eCollection 2021. PMID: 34290534; PMCID: PMC8289365.
Copy Download .nbib Format: NLM
Mechanical Performance of Knitted Hollow Composites from Recycled Cotton and Glass Fibers for Packaging Applications.

Polymers

Jamshaid H, Mishra R, Zeeshan M, Zahid B, Basra SA, Tichy M, Muller M.
PMID: 34301138
Polymers (Basel). 2021 Jul 20;13(14). doi: 10.3390/polym13142381.

This research deals with the development of knitted hollow composites from recycled cotton fibers (RCF) and glass fibers (GF). These knitted hollow composites can be used for packaging of heavy weight products and components in aircrafts, marine crafts, automobiles,...

Cite
Jamshaid H, Mishra R, Zeeshan M, et al. Mechanical Performance of Knitted Hollow Composites from Recycled Cotton and Glass Fibers for Packaging Applications. Polymers (Basel). 2021;13(14)doi: 10.3390/polym13142381.
Jamshaid, H., Mishra, R., Zeeshan, M., Zahid, B., Basra, S. A., Tichy, M., & Muller, M. (2021). Mechanical Performance of Knitted Hollow Composites from Recycled Cotton and Glass Fibers for Packaging Applications. Polymers, 13(14), . https://doi.org/10.3390/polym13142381
Jamshaid, Hafsa, et al. "Mechanical Performance of Knitted Hollow Composites from Recycled Cotton and Glass Fibers for Packaging Applications." Polymers vol. 13,14 (2021). doi: https://doi.org/10.3390/polym13142381
Jamshaid H, Mishra R, Zeeshan M, Zahid B, Basra SA, Tichy M, Muller M. Mechanical Performance of Knitted Hollow Composites from Recycled Cotton and Glass Fibers for Packaging Applications. Polymers (Basel). 2021 Jul 20;13(14). doi: 10.3390/polym13142381. PMID: 34301138; PMCID: PMC8309673.
Copy Download .nbib Format: NLM
Thrombolysis for acute stroke under antiplatelet therapy: safe enough to be beneficial?.

Nature clinical practice. Neurology

Hacke W, Lichy C.
PMID: 18665145
Nat Clin Pract Neurol. 2008 Sep;4(9):474-5. doi: 10.1038/ncpneuro0867. Epub 2008 Jul 29.

Controversy exists over whether chronic antiplatelet therapy in patients with acute ischemic stroke is a contraindication to treatment with tissue plasminogen activator (tPA). Antiplatelets impair thrombocyte function and might, therefore, increase the risk of symptomatic intracerebral hemorrhage (SICH) after...

Cite
Hacke W, Lichy C. Thrombolysis for acute stroke under antiplatelet therapy: safe enough to be beneficial?. Nat Clin Pract Neurol. 2008;4(9):474-5doi: 10.1038/ncpneuro0867.
Hacke, W., & Lichy, C. (2008). Thrombolysis for acute stroke under antiplatelet therapy: safe enough to be beneficial?. Nature clinical practice. Neurology, 4(9), 474-5. https://doi.org/10.1038/ncpneuro0867
Hacke, Werner, and Lichy, Christoph. "Thrombolysis for acute stroke under antiplatelet therapy: safe enough to be beneficial?." Nature clinical practice. Neurology vol. 4,9 (2008): 474-5. doi: https://doi.org/10.1038/ncpneuro0867
Hacke W, Lichy C. Thrombolysis for acute stroke under antiplatelet therapy: safe enough to be beneficial?. Nat Clin Pract Neurol. 2008 Sep;4(9):474-5. doi: 10.1038/ncpneuro0867. Epub 2008 Jul 29. PMID: 18665145.
Copy Download .nbib Format: NLM
Running Coupling Constant from Position-Space Current-Current Correlation Functions in Three-Flavor Lattice QCD.

Physical review letters

Calì S, Cichy K, Korcyl P, Simeth J.
PMID: 33412018
Phys Rev Lett. 2020 Dec 11;125(24):242002. doi: 10.1103/PhysRevLett.125.242002.

In this Letter, we provide a determination of the coupling constant in three-flavor quantum chromodynamics (QCD), α_{s}^{MS[over ¯]}(μ), for MS[over ¯] renormalization scales μ∈(1,2)  GeV. The computation uses gauge field configuration ensembles with O(a)-improved Wilson-clover fermions generated by the...

Cite
Calì S, Cichy K, Korcyl P, et al. Running Coupling Constant from Position-Space Current-Current Correlation Functions in Three-Flavor Lattice QCD. Phys Rev Lett. 2020;125(24):242002doi: 10.1103/PhysRevLett.125.242002.
Calì, S., Cichy, K., Korcyl, P., & Simeth, J. (2020). Running Coupling Constant from Position-Space Current-Current Correlation Functions in Three-Flavor Lattice QCD. Physical review letters, 125(24), 242002. https://doi.org/10.1103/PhysRevLett.125.242002
Calì, Salvatore, et al. "Running Coupling Constant from Position-Space Current-Current Correlation Functions in Three-Flavor Lattice QCD." Physical review letters vol. 125,24 (2020): 242002. doi: https://doi.org/10.1103/PhysRevLett.125.242002
Calì S, Cichy K, Korcyl P, Simeth J. Running Coupling Constant from Position-Space Current-Current Correlation Functions in Three-Flavor Lattice QCD. Phys Rev Lett. 2020 Dec 11;125(24):242002. doi: 10.1103/PhysRevLett.125.242002. PMID: 33412018.
Copy Download .nbib Format: NLM
Maintenance of neutralizing antibodies over ten months in convalescent SARS-CoV-2 afflicted patients.

Transboundary and emerging diseases

Sonnleitner ST, Prelog M, Jansen B, Rodgarkia-Dara C, Gietl S, Schönegger CM, Koblmüller S, Sturmbauer C, Posch W, Almanzar G, Jury H, Loney T, Tichy A, Nowotny N, Walder G.
PMID: 33960696
Transbound Emerg Dis. 2021 May 07; doi: 10.1111/tbed.14130. Epub 2021 May 07.

Knowledge of the level and duration of protective immunity against SARS-CoV-2 after primary infection is of crucial importance for preventive approaches. Currently, there is a lack of evidence on the persistence of specific antibodies. We investigated the generation and...

Cite
Sonnleitner ST, Prelog M, Jansen B, et al. Maintenance of neutralizing antibodies over ten months in convalescent SARS-CoV-2 afflicted patients. Transbound Emerg Dis. 2021;doi: 10.1111/tbed.14130.
Sonnleitner, S. T., Prelog, M., Jansen, B., Rodgarkia-Dara, C., Gietl, S., Schönegger, C. M., Koblmüller, S., Sturmbauer, C., Posch, W., Almanzar, G., Jury, H., Loney, T., Tichy, A., Nowotny, N., & Walder, G. (2021). Maintenance of neutralizing antibodies over ten months in convalescent SARS-CoV-2 afflicted patients. Transboundary and emerging diseases, . https://doi.org/10.1111/tbed.14130
Sonnleitner, Sissy Therese, et al. "Maintenance of neutralizing antibodies over ten months in convalescent SARS-CoV-2 afflicted patients." Transboundary and emerging diseases vol. (2021). doi: https://doi.org/10.1111/tbed.14130
Sonnleitner ST, Prelog M, Jansen B, Rodgarkia-Dara C, Gietl S, Schönegger CM, Koblmüller S, Sturmbauer C, Posch W, Almanzar G, Jury H, Loney T, Tichy A, Nowotny N, Walder G. Maintenance of neutralizing antibodies over ten months in convalescent SARS-CoV-2 afflicted patients. Transbound Emerg Dis. 2021 May 07; doi: 10.1111/tbed.14130. Epub 2021 May 07. PMID: 33960696; PMCID: PMC8242897.
Copy Download .nbib Format: NLM
Attitudes towards lockdown, trust in institutions, and civic engagement: A study on Sicilians during the coronavirus lockdown.

Journal of public affairs

Di Marco G, Hichy Z, Sciacca F.
PMID: 34512191
J Public Aff. 2021 Aug 11;e2739. doi: 10.1002/pa.2739. Epub 2021 Aug 11.

Italy was the first European country to be affected by the Covid-19. To limit the contagion, an emergency protocol was triggered on March 10, 2020, which imposed a lockdown for 69 days. Many Italians considered the restrictions imposed by...

Cite
Di Marco G, Hichy Z, Sciacca F. Attitudes towards lockdown, trust in institutions, and civic engagement: A study on Sicilians during the coronavirus lockdown. J Public Aff. 2021;e2739doi: 10.1002/pa.2739.
Di Marco, G., Hichy, Z., & Sciacca, F. (2021). Attitudes towards lockdown, trust in institutions, and civic engagement: A study on Sicilians during the coronavirus lockdown. Journal of public affairs, e2739. https://doi.org/10.1002/pa.2739
Di Marco, Graziella, et al. "Attitudes towards lockdown, trust in institutions, and civic engagement: A study on Sicilians during the coronavirus lockdown." Journal of public affairs vol. (2021): e2739. doi: https://doi.org/10.1002/pa.2739
Di Marco G, Hichy Z, Sciacca F. Attitudes towards lockdown, trust in institutions, and civic engagement: A study on Sicilians during the coronavirus lockdown. J Public Aff. 2021 Aug 11;e2739. doi: 10.1002/pa.2739. Epub 2021 Aug 11. PMID: 34512191; PMCID: PMC8420251.
Copy Download .nbib Format: NLM
Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options.

Blood

Malcikova J, Pavlova S, Barbara KV, Radova L, Plevova K, Kotaskova J, Pal K, Dvorackova B, Zenatova M, Hynst J, Ondrouskova E, Panovska A, Brychtova Y, Zavacka K, Tichy B, Tom N, Mayer J, Doubek M, Pospisilova S.
PMID: 33945616
Blood. 2021 Dec 23;138(25):2670-2685. doi: 10.1182/blood.2020009530.

Patients with chronic lymphocytic leukemia (CLL) bearing TP53 mutations experience chemorefractory disease and are therefore candidates for targeted therapy. However, the significance of low-burden TP53 mutations with

Cite
Malcikova J, Pavlova S, Barbara KV, et al. Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options. Blood. 2021;138(25):2670-2685doi: 10.1182/blood.2020009530.
Malcikova, J., Pavlova, S., Barbara, K. V., Radova, L., Plevova, K., Kotaskova, J., Pal, K., Dvorackova, B., Zenatova, M., Hynst, J., Ondrouskova, E., Panovska, A., Brychtova, Y., Zavacka, K., Tichy, B., Tom, N., Mayer, J., Doubek, M., & Pospisilova, S. (2021). Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options. Blood, 138(25), 2670-2685. https://doi.org/10.1182/blood.2020009530
Malcikova, Jitka, et al. "Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options." Blood vol. 138,25 (2021): 2670-2685. doi: https://doi.org/10.1182/blood.2020009530
Malcikova J, Pavlova S, Barbara KV, Radova L, Plevova K, Kotaskova J, Pal K, Dvorackova B, Zenatova M, Hynst J, Ondrouskova E, Panovska A, Brychtova Y, Zavacka K, Tichy B, Tom N, Mayer J, Doubek M, Pospisilova S. Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options. Blood. 2021 Dec 23;138(25):2670-2685. doi: 10.1182/blood.2020009530. PMID: 33945616.
Copy Download .nbib Format: NLM
Arthropathic psoriasis complicated by a paradoxical reaction in the form of erythrodermic psoriasis following adalimumab and by an allergic reaction following infliximab which was successfully managed with secukinumab.

Postepy dermatologii i alergologii

Tichy M.
PMID: 31616228
Postepy Dermatol Alergol. 2019 Aug;36(4):495-497. doi: 10.5114/ada.2019.87454. Epub 2019 Aug 30.

No abstract available.

Cite
Tichy M. Arthropathic psoriasis complicated by a paradoxical reaction in the form of erythrodermic psoriasis following adalimumab and by an allergic reaction following infliximab which was successfully managed with secukinumab. Postepy Dermatol Alergol. 2019;36(4):495-497doi: 10.5114/ada.2019.87454.
Tichy, M. (2019). Arthropathic psoriasis complicated by a paradoxical reaction in the form of erythrodermic psoriasis following adalimumab and by an allergic reaction following infliximab which was successfully managed with secukinumab. Postepy dermatologii i alergologii, 36(4), 495-497. https://doi.org/10.5114/ada.2019.87454
Tichy, Martin. "Arthropathic psoriasis complicated by a paradoxical reaction in the form of erythrodermic psoriasis following adalimumab and by an allergic reaction following infliximab which was successfully managed with secukinumab." Postepy dermatologii i alergologii vol. 36,4 (2019): 495-497. doi: https://doi.org/10.5114/ada.2019.87454
Tichy M. Arthropathic psoriasis complicated by a paradoxical reaction in the form of erythrodermic psoriasis following adalimumab and by an allergic reaction following infliximab which was successfully managed with secukinumab. Postepy Dermatol Alergol. 2019 Aug;36(4):495-497. doi: 10.5114/ada.2019.87454. Epub 2019 Aug 30. PMID: 31616228; PMCID: PMC6791146.
Copy Download .nbib Format: NLM
Orbital climate variability on the northeastern Tibetan Plateau across the Eocene-Oligocene transition.

Nature communications

Ao H, Dupont-Nivet G, Rohling EJ, Zhang P, Ladant JB, Roberts AP, Licht A, Liu Q, Liu Z, Dekkers MJ, Coxall HK, Jin Z, Huang C, Xiao G, Poulsen CJ, Barbolini N, Meijer N, Sun Q, Qiang X, Yao J, An Z.
PMID: 33067447
Nat Commun. 2020 Oct 16;11(1):5249. doi: 10.1038/s41467-020-18824-8.

The first major build-up of Antarctic glaciation occurred in two consecutive stages across the Eocene-Oligocene transition (EOT): the EOT-1 cooling event at ~34.1-33.9 Ma and the Oi-1 glaciation event at ~33.8-33.6 Ma. Detailed orbital-scale terrestrial environmental responses to these...

Cite
Ao H, Dupont-Nivet G, Rohling EJ, et al. Orbital climate variability on the northeastern Tibetan Plateau across the Eocene-Oligocene transition. Nat Commun. 2020;11(1):5249doi: 10.1038/s41467-020-18824-8.
Ao, H., Dupont-Nivet, G., Rohling, E. J., Zhang, P., Ladant, J. B., Roberts, A. P., Licht, A., Liu, Q., Liu, Z., Dekkers, M. J., Coxall, H. K., Jin, Z., Huang, C., Xiao, G., Poulsen, C. J., Barbolini, N., Meijer, N., Sun, Q., Qiang, X., Yao, J., & An, Z. (2020). Orbital climate variability on the northeastern Tibetan Plateau across the Eocene-Oligocene transition. Nature communications, 11(1), 5249. https://doi.org/10.1038/s41467-020-18824-8
Ao, Hong, et al. "Orbital climate variability on the northeastern Tibetan Plateau across the Eocene-Oligocene transition." Nature communications vol. 11,1 (2020): 5249. doi: https://doi.org/10.1038/s41467-020-18824-8
Ao H, Dupont-Nivet G, Rohling EJ, Zhang P, Ladant JB, Roberts AP, Licht A, Liu Q, Liu Z, Dekkers MJ, Coxall HK, Jin Z, Huang C, Xiao G, Poulsen CJ, Barbolini N, Meijer N, Sun Q, Qiang X, Yao J, An Z. Orbital climate variability on the northeastern Tibetan Plateau across the Eocene-Oligocene transition. Nat Commun. 2020 Oct 16;11(1):5249. doi: 10.1038/s41467-020-18824-8. PMID: 33067447; PMCID: PMC7567875.
Copy Download .nbib Format: NLM
Matching Quantitative MRI Parameters with Histological Features of Treatment-Naïve .

Cancers

Maurer GD, Tichy J, Harter PN, Nöth U, Weise L, Quick-Weller J, Deichmann R, Steinbach JP, Bähr O, Hattingen E.
PMID: 34439213
Cancers (Basel). 2021 Aug 12;13(16). doi: 10.3390/cancers13164060.

Quantitative MRI allows to probe tissue properties by measuring relaxation times and may thus detect subtle changes in tissue composition. In this work we analyzed different relaxation times (T1, T2, T2* and T2') and histological features in 321 samples...

Cite
Maurer GD, Tichy J, Harter PN, et al. Matching Quantitative MRI Parameters with Histological Features of Treatment-Naïve . Cancers (Basel). 2021;13(16)doi: 10.3390/cancers13164060.
Maurer, G. D., Tichy, J., Harter, P. N., Nöth, U., Weise, L., Quick-Weller, J., Deichmann, R., Steinbach, J. P., Bähr, O., & Hattingen, E. (2021). Matching Quantitative MRI Parameters with Histological Features of Treatment-Naïve . Cancers, 13(16), . https://doi.org/10.3390/cancers13164060
Maurer, Gabriele D, et al. "Matching Quantitative MRI Parameters with Histological Features of Treatment-Naïve ." Cancers vol. 13,16 (2021). doi: https://doi.org/10.3390/cancers13164060
Maurer GD, Tichy J, Harter PN, Nöth U, Weise L, Quick-Weller J, Deichmann R, Steinbach JP, Bähr O, Hattingen E. Matching Quantitative MRI Parameters with Histological Features of Treatment-Naïve . Cancers (Basel). 2021 Aug 12;13(16). doi: 10.3390/cancers13164060. PMID: 34439213; PMCID: PMC8392045.
Copy Download .nbib Format: NLM
Double-Walled Poly-(D,L-lactide-co-glycolide) (PLGA) and Poly(L-lactide) (PLLA) Nanoparticles for the Sustained Release of Doxorubicin.

Polymers

Cardoso MM, Peca IN, Lopes T, Gardner R, Bicho A.
PMID: 34641046
Polymers (Basel). 2021 Sep 23;13(19). doi: 10.3390/polym13193230.

Double-walled nanoparticles (DWNPs), containing doxorubicin as a model drug, were produced using poly-(D,L-lactide-co-glycolide) (PLGA) and poly(L-lactide) (PLLA) by the solvent evaporation technique. Double-walled microparticles containing doxorubicin were also produced to make possible the examination of the inner morphology and...

Cite
Cardoso MM, Peca IN, Lopes T, et al. Double-Walled Poly-(D,L-lactide-co-glycolide) (PLGA) and Poly(L-lactide) (PLLA) Nanoparticles for the Sustained Release of Doxorubicin. Polymers (Basel). 2021;13(19)doi: 10.3390/polym13193230.
Cardoso, M. M., Peca, I. N., Lopes, T., Gardner, R., & Bicho, A. (2021). Double-Walled Poly-(D,L-lactide-co-glycolide) (PLGA) and Poly(L-lactide) (PLLA) Nanoparticles for the Sustained Release of Doxorubicin. Polymers, 13(19), . https://doi.org/10.3390/polym13193230
Cardoso, M Margarida, et al. "Double-Walled Poly-(D,L-lactide-co-glycolide) (PLGA) and Poly(L-lactide) (PLLA) Nanoparticles for the Sustained Release of Doxorubicin." Polymers vol. 13,19 (2021). doi: https://doi.org/10.3390/polym13193230
Cardoso MM, Peca IN, Lopes T, Gardner R, Bicho A. Double-Walled Poly-(D,L-lactide-co-glycolide) (PLGA) and Poly(L-lactide) (PLLA) Nanoparticles for the Sustained Release of Doxorubicin. Polymers (Basel). 2021 Sep 23;13(19). doi: 10.3390/polym13193230. PMID: 34641046; PMCID: PMC8512961.
Copy Download .nbib Format: NLM
Orbital variations as a major driver of climate and biome distribution during the greenhouse to icehouse transition.

Science advances

Tardif D, Toumoulin A, Fluteau F, Donnadieu Y, Le Hir G, Barbolini N, Licht A, Ladant JB, Sepulchre P, Viovy N, Hoorn C, Dupont-Nivet G.
PMID: 34678067
Sci Adv. 2021 Oct 22;7(43):eabh2819. doi: 10.1126/sciadv.abh2819. Epub 2021 Oct 22.

[Figure: see text].

Cite
Tardif D, Toumoulin A, Fluteau F, et al. Orbital variations as a major driver of climate and biome distribution during the greenhouse to icehouse transition. Sci Adv. 2021;7(43):eabh2819doi: 10.1126/sciadv.abh2819.
Tardif, D., Toumoulin, A., Fluteau, F., Donnadieu, Y., Le Hir, G., Barbolini, N., Licht, A., Ladant, J. B., Sepulchre, P., Viovy, N., Hoorn, C., & Dupont-Nivet, G. (2021). Orbital variations as a major driver of climate and biome distribution during the greenhouse to icehouse transition. Science advances, 7(43), eabh2819. https://doi.org/10.1126/sciadv.abh2819
Tardif, Delphine, et al. "Orbital variations as a major driver of climate and biome distribution during the greenhouse to icehouse transition." Science advances vol. 7,43 (2021): eabh2819. doi: https://doi.org/10.1126/sciadv.abh2819
Tardif D, Toumoulin A, Fluteau F, Donnadieu Y, Le Hir G, Barbolini N, Licht A, Ladant JB, Sepulchre P, Viovy N, Hoorn C, Dupont-Nivet G. Orbital variations as a major driver of climate and biome distribution during the greenhouse to icehouse transition. Sci Adv. 2021 Oct 22;7(43):eabh2819. doi: 10.1126/sciadv.abh2819. Epub 2021 Oct 22. PMID: 34678067; PMCID: PMC8535791.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 190 entries